RxDoctor Payments Data

Kathleen Mullane

Infectious Disease · Chicago, ILNPI 1831251388

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $37,636 of the $58,945 with a category attached, or 63.8%. 8 manufacturers reported payments, led by Merck at 48.7% of the total. Reporting peaked in 2019 at $41,823 and has fallen 97.3% since, to $1,109 in 2022. Among infectious disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$58,945in general payments, 2019–2025

Across 64 payments — averaging $921.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$29K
  • GSK$11K
  • Gilead$5K
  • ADMA Biomanufacturing LLC$5K
  • Paratek Pharmaceuticals, Inc.$5K
  • Astellas Pharma US Inc$2K
  • plus $2K from 2 others
$4,347,985in research payments, 2019–2025

Across 344 payments — averaging $12,639 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$3.6M
  • Merck$423K
  • Astellas Pharma Global Development$145K
  • Roche Products Limited$62K
  • Pfizer$35K
  • Qiagen, LLC$14K
  • plus $36K from 7 others

What the payments were for

  • Consulting fees$37,63664%
  • Speaking & faculty fees$16,20027%
  • Travel & lodging$3,9107%
  • Food & beverage$1,0212%
  • Education$1790%

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$58,945 in reported general payments places this provider in the 95th percentile of 368 infectious disease providers in Illinois.

See all infectious disease providers in Illinois

Other infectious disease in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →